ProCE Banner Activity

Recent Therapeutic Advances in Advanced SCLC


Download this slideset, curated by Dr Carl M Gay, to get up to date on the latest data on novel biomarker-driven therapies with promise to transform management of extensive-stage SCLC and research efforts to define therapeutic SCLC subtypes.

Released: March 25, 2024

Expiration: March 24, 2025



Carl M. Gay

Carl M. Gay, MD, PhD

Assistant Professor
Department of Thoracic/Head & Neck Oncology
University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Amgen and AstraZeneca Pharmaceuticals.


AstraZeneca Pharmaceuticals